Team-Based Management of Immunotherapy-Related Toxicities |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Preparing to Launch: What You Need to Know (But No One Ever Told You) About Entering the Oncology Workforce |
1.25 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Plenary Session - Living with Lynch Syndrome: A Patient Story |
1.25 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Management of Trauma-Related and Stressor-Related Disorders |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Team-Based Case Review: Breast Cancer |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Appropriate Vaccinations for Patients in Survivorship |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Variations in Breast Cancer Screening Recommendations |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Management of MSI-H/dMMR Upper and Lower Gastrointestinal Cancers |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Updates to the Management of Multiple Myeloma |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Updates in the Management of Locally Advanced Rectal Cancer |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
New Targeted Therapies for Metastatic Non-Small Cell Lung Cancer |
1.00 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Acute Myeloid Leukemia: Role of FLT3 Inhibitors After Allogeneic Hematopoietic Cell Transplantation |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Team-Based Case Review: Colorectal Cancer |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Updates to the Management of HR-Positive, HER2-Negative Breast Cancer |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |
Management of Renal Cell Carcinoma |
0.75 |
06/15/2024 - 12:00am to 03/01/2025 - 12:00am |